Searched for
RANBAXY PRODUCTS
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- German ban on Ranbaxy's Dewas product expands to entire EUAdding to Ranbaxy's regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export to all member coun...
- Sun Pharma to firm up steps to boost Ranbaxy drug salesThe drug maker also plans to draw up detailed cross-selling plans for each state, according to industry consultants familiar with the matte...
- Sun Pharma to buy Ranbaxy in $3.2 bn deal: HighlightsSun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...
- Ranbaxy sets aside Rs 257.4 crore for impact of USFDA banRanbaxy Laboratories has set aside Rs 257.4 crore towards the financial impact of a US ban on import of products made at its plant at Toans...
- EU, UK evaluating FDA findings on Ranbaxy's Toansa facilityDays after US FDA banned import of Ranbaxy products to America from its Toansa plant, health regulators of EU & UK have said they are evalu...
- Ranbaxy drugs safe says Australian drug regulator"At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality".
- Ranbaxy drugs fine, say WHO, UK regulatorUK has issued a statement clarifying that they have found no evidence that any of Ranbaxy’s products in the UK market “are or have been of ...
- Resolved the matter with Ranbaxy: Apollo PharmacyApollo Pharmacy today said it has resolved the matter and will continue to sell Ranbaxy's medicines from its outlets across the country.
- Hospitals, chemists to wait for regulatory word on RanbaxyDGCI is confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products
- Ranbaxy reassures South Africans local drugs are safeRanbaxy has assured the public that drugs manufactured locally are safe days after the Indian firm paid a fine of $500 million in the US.
- Our current drugs in India, global markets safe: RanbaxyRanbaxy today claimed that its "products currently in the Indian market and globally are safe and efficacious".
- Our current drugs in India, global markets safe: RanbaxyBeleaguered drug maker Ranbaxy claimed its "products currently in the Indian market and globally are safe and efficacious".
- Daiichi Sankyo and Ranbaxy Launch hybrid business in VenezuelaDaiichi Sankyo & Ranbaxy announced that Daiichi Sankyo Venezuela would begin marketing Ranbaxy products in Venezuela as part of hybrid busi...
- Daiichi sets up firm to market Ranbaxy products in JapanRanbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.
- Ranbaxy receives regulatory nod for Poanta Sahib plantRanbaxy Laboratories has received regulatory nod for its Poanta Sahib plant in Himachal Pradesh from European and Australian drug regulator...
- US FDA blocks imports from Ranbaxy for poor qualityFDA move does not end US sales by Ranbaxy. The factories with defects are in Dewas and Paonta Sahib. The Top 10 food myths revealed | Bewar...
Load More
